Kristina Pentieva

ORCID: 0000-0003-2059-534X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Folate and B Vitamins Research
  • Agricultural safety and regulations
  • Consumer Attitudes and Food Labeling
  • Food Allergy and Anaphylaxis Research
  • Birth, Development, and Health
  • Nutritional Studies and Diet
  • Metabolism and Genetic Disorders
  • Infant Nutrition and Health
  • Diet and metabolism studies
  • Vitamin K Research Studies
  • Esophageal and GI Pathology
  • Effects and risks of endocrine disrupting chemicals
  • Digestive system and related health
  • Nutrition and Health in Aging
  • Child Nutrition and Feeding Issues
  • Pregnancy and preeclampsia studies
  • Trace Elements in Health
  • Iron Metabolism and Disorders
  • Epigenetics and DNA Methylation
  • Vitamin C and Antioxidants Research
  • Sodium Intake and Health
  • Heavy Metal Exposure and Toxicity
  • Probiotics and Fermented Foods
  • Vitamin D Research Studies
  • Protein Hydrolysis and Bioactive Peptides

University of Ulster
2014-2024

Food for Health Ireland
2005-2024

Trinity College Dublin
2001-2023

University of Wisconsin–Madison
2023

University of Pisa
2023

Health Canada
2023

Cyprus University of Technology
2021

Novel (United States)
2018

Academy of Nutrition and Dietetics
2016-2017

Northern Health and Social Care Trust
2011

Following the adoption of Regulation (EU) 2015/2283 European Parliament and Council on novel foods, Commission requested EFSA to update develop scientific technical guidance for preparation presentation applications authorisation foods.This presents a common format organisation information be presented in order assist applicant preparing well-structured application demonstrate safety food.The should comprehensive complete.This outlined data needed assessments foods.Requirements which covered...

10.2903/j.efsa.2016.4594 article EN cc-by-nd EFSA Journal 2016-11-01

Following a request from the European Commission, EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) derives dietary reference values (DRVs) for vitamin K. In this Opinion, considers K to comprise both phylloquinone menaquinones. The that none of biomarkers intake or status is suitable by itself derive DRVs Several health outcomes possibly associated with were also considered but data could not be used establish DRVs. average requirements population intakes cannot derived adults,...

10.2903/j.efsa.2017.4780 article EN cc-by-nd EFSA Journal 2017-05-01

Following a request from the European Commission, EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) derived dietary reference values (DRVs) for sodium. Evidence balance studies sodium relationship between intake health outcomes, in particular cardiovascular disease (CVD)-related endpoints bone health, was reviewed. The data were not sufficient to enable an average requirement (AR) or population (PRI) be derived. However, by integrating available evidence associated uncertainties,...

10.2903/j.efsa.2019.5778 article EN cc-by-nd EFSA Journal 2019-09-01

Following a request from the European Commission, EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver scientific opinion tolerable upper intake level (UL) for selenium. Systematic reviews of literature were conducted identify evidence regarding excess selenium clinical effects potential biomarkers effect, risk chronic diseases impaired neuropsychological development in humans. Alopecia, as an early observable feature well-established adverse effect exposure, is...

10.2903/j.efsa.2023.7704 article EN cc-by-nd EFSA Journal 2023-01-01

Folate intake is strongly influenced by various methods of cooking that can degrade the natural forms vitamin in foods. The aim present study was to determine effect different on folate retention foods contribute UK diet. Typical purchasing and practices representative food sources were determined from a questionnaire survey local shoppers ( n 100). Total microbiological assay Lactobacillus casei NCIMB 10463) following thermal extraction tri-enzyme (α-amylase, protease conjugase) treatment...

10.1079/bjn2002733 article EN British Journal Of Nutrition 2002-12-01

Following a request from the European Commission, Panel on Nutrition, Novel Foods and Food Allergens (NDA) revised its 2009 Opinion appropriate age for introduction of complementary feeding infants. This has been evaluated considering effects health outcomes, nutritional aspects infant development, depends individual's characteristics development. As long as foods have an age-appropriate texture, are nutritionally prepared following good hygiene practices, there is no convincing evidence...

10.2903/j.efsa.2019.5780 article EN cc-by-nd EFSA Journal 2019-09-01

EFSA asked the Panel on Dietetic Products, Nutrition and Allergies (NDA) to update guidance scientific requirements for health claims related antioxidants, oxidative damage cardiovascular published in 2011. The takes into accounts experiences gained with evaluation of additional claim applications health, information collected from a Grant launched 2014. This is intended assist applicants preparing authorisation health. document was subject public consultation (from 12 July 3 September...

10.2903/j.efsa.2018.5136 article EN cc-by-nd EFSA Journal 2018-01-01

Following a request from the European Commission, EFSA Panel on Nutrition, Novel Food and Allergens (NDA) was asked to deliver an opinion safety of frozen dried formulations house crickets (Acheta domesticus) as novel food pursuant Regulation (EU) 2015/2283. The NF is proposed in three formulations: (i) frozen, (ii) dried, (iii) ground. main components are protein, fat fibre (chitin) form NF, water, NF. notes that concentrations contaminants depend occurrence levels these substances insect...

10.2903/j.efsa.2021.6779 article EN EFSA Journal 2021-08-01

Abstract Background Periconceptional folic acid prevents neural tube defects (NTDs), but it is uncertain whether there are benefits for offspring neurodevelopment arising from continued maternal supplementation beyond the first trimester. We investigated effect of during trimesters 2 and 3 pregnancy on cognitive performance in child. Methods followed up children mothers who had participated a randomized controlled trial 2006/2007 Folic Acid Supplementation Second Third Trimesters (FASSTT)...

10.1186/s12916-019-1432-4 article EN cc-by BMC Medicine 2019-10-31

Following a request from the European Commission, EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion frozen dried formulations whole yellow mealworm (Tenebrio molitor larva) as novel food (NF) pursuant Regulation (EU) 2015/2283. The term refers larval form of insect species Tenebrio molitor. NF comprises freeze-dried mealworm, or in powder. formulation consists mainly water, crude protein fat whereas protein, fat, digestible carbohydrates fibre...

10.2903/j.efsa.2021.6778 article EN cc-by-nd EFSA Journal 2021-08-01

The European Commission has determined that cannabidiol (CBD) can be considered as a novel food (NF), and currently, 19 applications are under assessment at EFSA. While assessing these, it become clear there knowledge gaps need to addressed before conclusion on the safety of CBD reached. Consequently, EFSA issued this statement, summarising state consumption highlighting areas where more data needed. Literature searches for both animal human studies have been conducted identify concerns....

10.2903/j.efsa.2022.7322 article EN cc-by-nd EFSA Journal 2022-06-01

Vitamins and essential minerals are micronutrients that for the normal functioning of human body. However, they may lead to adverse health effects if consumed in excess. The concept a tolerable upper intake level (UL) is science-based reference value, which was introduced support policy-makers other relevant actors managing risks excess nutrient intake. EFSA's principles establishing ULs vitamins were originally developed by Scientific Committee on Food 2000. Since then, experience has been...

10.2903/j.efsa.2022.e200102 article EN EFSA Journal 2022-01-01

Following a request from the European Commission, EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver scientific advice related nutrient profiling for development of harmonised mandatory front-of-pack nutrition labelling setting profiles restricting health claims foods. This Opinion is based systematic reviews meta-analyses human studies nutritionally adequate diets, data Global Burden Disease framework, clinical practice guidelines, previous opinions...

10.2903/j.efsa.2022.7259 article EN cc-by-nd EFSA Journal 2022-04-01

Following two requests from the European Commission (EC), EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver a scientific opinion revision of tolerable upper intake level (UL) for vitamin D propose conversion factor (CF) calcidiol monohydrate into

10.2903/j.efsa.2023.8145 article EN cc-by-nd EFSA Journal 2023-08-01

ABSTRACT Following a request from the European Commission (EC), EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver scientific opinion revision of tolerable upper intake level (UL) for folic acid/folate. Systematic reviews literature were conducted assess evidence priority adverse health effects excess folate (including acid other authorised forms, (6S)-5-methyltetrahydrofolic glucosamine l-5-methyltetrahydrofolic calcium salts), namely risk cobalamin-dependent...

10.2903/j.efsa.2023.8353 article EN cc-by-nd EFSA Journal 2023-11-01

Abstract The European Commission requested EFSA to update the scientific guidance for preparation of applications authorisation novel foods, previously developed following adoption Regulation (EU) 2015/2283 on foods. This document provides advice information needed be submitted by applicant towards demonstrating safety food. Requirements pertain description food, production process, compositional data, specifications, proposed uses and use levels anticipated intake Furthermore, in sections...

10.2903/j.efsa.2024.8961 article EN cc-by-nd EFSA Journal 2024-09-01

Abstract The European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability for use in infant follow‐on formula of a specific protein hydrolysate from whey concentrate manufactured by Fonterra Co‐operative Group Ltd. submitted dossier request amendment Regulation (EU) 2016/127 with respect sources that may be used manufacture and/or formula. under evaluation is sufficiently characterised hydrolysed protein. In pertinent intervention study provided, content 2.0...

10.2903/j.efsa.2025.9160 article EN cc-by-nd EFSA Journal 2025-01-01
Coming Soon ...